2-(acetylamino)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylic acid, 95.0%, 1g

(4-ethoxyphenyl)(piperidin-4-yl)methanol, 95.0%, 1g

6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-9H-purine, 95.0%, 5g

7-Chloro-2-hydroxyquinoline, 95.0%, 10g

2-(5-methyl-1H-indol-3-yl)-2-[3-(trifluoromethyl)phenyl]ethanamine, 50mg

(R)-2-(Fluoromethyl)morpholine hydrochloride, 98%, 100mg

4-Benzyloxy-3-fluorophenylboronic acid, 97.0%, 100g

(2E)-1-(3-chlorophenyl)-3-(2,4-dichlorophenyl)prop-2-en-1-one, 95.0%, 2g

(3-BROMO-1-METHYL-1H-1,2,4-TRIAZOL-5-YL)METHANOL, 95%, 5g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 150, 4000 ml, 190 mm, 1 Piece

4,4,5,5-Tetramethyl-2-(5-methylfuran-2-yl)-1,3,2-dioxaborolane, 95.0%, 5g

2-Bromo-4-trifluoromethoxybenzenesulfonyl chloride, 250mg

Tolmetin>98.0%(HPLC)(T)1g